Article Type
Changed
Tue, 05/03/2022 - 16:11
Display Headline
How should patients taking the discontinued diabetes drug troglitazone be managed?
Article PDF
Author and Disclosure Information

S. Sethu K. Reddy, MD
Department of Endocrinology, Cleveland Clinic

Address: S. Sethu K. Reddy, MD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Reddy has indicated that he serves on the speakers' bureaus of the Parke-Davis, SmithKline Beecham, Eli Lilly, Takeda, Bristol-Myers Squibb, Aventis, Pfizer, Novo-Nordisk, and Schering companies, all of which make products for diabetes care.

Issue
Cleveland Clinic Journal of Medicine - 67(6)
Publications
Topics
Page Number
401-402
Sections
Author and Disclosure Information

S. Sethu K. Reddy, MD
Department of Endocrinology, Cleveland Clinic

Address: S. Sethu K. Reddy, MD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Reddy has indicated that he serves on the speakers' bureaus of the Parke-Davis, SmithKline Beecham, Eli Lilly, Takeda, Bristol-Myers Squibb, Aventis, Pfizer, Novo-Nordisk, and Schering companies, all of which make products for diabetes care.

Author and Disclosure Information

S. Sethu K. Reddy, MD
Department of Endocrinology, Cleveland Clinic

Address: S. Sethu K. Reddy, MD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Reddy has indicated that he serves on the speakers' bureaus of the Parke-Davis, SmithKline Beecham, Eli Lilly, Takeda, Bristol-Myers Squibb, Aventis, Pfizer, Novo-Nordisk, and Schering companies, all of which make products for diabetes care.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 67(6)
Issue
Cleveland Clinic Journal of Medicine - 67(6)
Page Number
401-402
Page Number
401-402
Publications
Publications
Topics
Article Type
Display Headline
How should patients taking the discontinued diabetes drug troglitazone be managed?
Display Headline
How should patients taking the discontinued diabetes drug troglitazone be managed?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media